Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Curious about your investment portfolio? Discover what to include to ensure a balanced and profitable mix of assets.
23,656 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
When prices surge, some firms enjoy sudden profits. This piece explains why the corporate income tax already taxes th...
When the market shakes off retail names, patient investors can spot opportunities. Here are two retail growth stocks ...
A hidden AI stock is drawing quiet attention. This article breaks down why investors are eyeing it before its next ea...
IonQ stock recently popped in active trading, fueled by rival news and renewed optimism around quantum tech. This gui...
Investing in AI requires more than hype. This guide explains how a Nvidia-backed infrastructure stock hand can unlock...
Copart director Daniel Englander recently sold 80,000 shares for about $2.2 million. With CPRT down roughly 40%, inve...
As inflation stays in focus for 2026, investors are rethinking retirement allocations. A diversified commodity ETF of...
Joby Aviation just crossed a major regulatory milestone, but what does that mean for investors? This in-depth guide b...
Plug Power has captured attention as its revenue growth accelerates amid a reshaped hydrogen market. This article bre...
Insider activity can shed light on a company's future. This deep dive examines Perdoceo Education's $1.8 million insi...
A 67-year-old retiree can add roughly $50,000 a year from self-employment without reducing Social Security benefits, ...